Fludarabine, Cyclophosphamide and Mitoxantrone for Untreated Follicular Lymphoma: a Report from the Non-Hodgkin's Lymphoma Co-operative Study Group

Reference

• Rosenberg, S.A. (1985) "The low-grade non-Hodgkin's lymphomas: challenges and opportunities", Journal of Clinical Oncology, 3, 299 — 310.
   PubMedGoogle Scholar
• Horning, S.J. (1993) "Natural history of and therapy for the indolent non-Hodgkin's lymphomas", Seminars in Oncology, 20\(Suppl 5), 75–88.
   PubMed Web of Science ®Google Scholar
• Young, R.C., Longo, D.L., Glatstein, E., et al. (1988) "The treatment of indolent lymphomas : watchful waiting v aggressive combined treatment", Seminars in Oncology, 2\(Suppl 2), 11 — 16.
   Google Scholar
• Dana, B.W., Dahlberg, S., Nathwani, B.N., et al. (1993) "Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmu-notherapy", Journal of Clinical Oncology, 4, 644–651.
   Google Scholar
• Federico, M., Vitolo, U., Zinzani, P.L., et al. (2000) "Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases", Blood, 95, 783–789.
   Google Scholar
• Price, C.G.A., Meerabwc, J., Murtag, S., et al. (1991) "The significance of circulating cell carrying t (14;18) in long remission from follicular lymphoma", Journal of Clinical Oncology, 9, 1527 — 1532.
   Google Scholar
• Gribben, J.G., Freedman, A.S., Woo, S.D., et al. (1991) "All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bc1-2 have residual cells contain-ing the bc1-2 rearrangement at evaluation and after treatment", Blood, 78, 3275 — 3280.
   Google Scholar
• McLaughlin, P., Hagemeister, F.B., Swan, F., et al. (1994) "Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bc1-2 rearrangement", Annals of Oncology, 5\(Suppl 2), S73–577.
   PubMed Web of Science ®Google Scholar
• LOpez-Guillermo, A., Cabanillas, F., McLaughlin, P., et al. (1998) "The clinical significance of molecular response in indolent follicular lymphomas", Blood, 8, 2955–2960.
   Google Scholar
• McLaughlin, P., Hagemeister, F.B., Romaguera, J.E., et al. (1996) "Fludarabine, mitoxantrone, and dexamethasone. An effective new regimen for indolent lymphoma", Journal of Clinical Oncology, 14, 1262 — 1268.
   Web of Science ®Google Scholar
• Zinzani, P.L., Bendandi, M., Magagnali, M., et al. (1997) "Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma", Annals of Oncol-ogy, 8, 379–383.
   Google Scholar
• Bosch, F., Perales, M., Cobo, F., et al. (1997) "Fludarabine, cyclophosphamide and mitoxantrone (FCM) therapy in resistant or relapsed chronic lymphocytic leukemia (CLL) or follicular lympho-ma (FL)", Blood, 90\(suppl. 1), abs. 2360.
   Google Scholar
• Lazzarino, M., Orlandi, E., Montillo, M., et al. (1999) "Fludar-abine, cyclophosphamide, and dexamethasone (FluCyD) combina-tion is effective in pre-treated low-grade non-Hodgkin's lymphoma", Annals of Oncology, 10, 59–64.
   Google Scholar
• Santini, G., Nati, S., Spriano, M., et al. (2001) "Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma", Haematologica, 86, 282–286.
   Google Scholar
• Zinzani, P.L., Magagnali, M., Moretti, L., et al. (2000) "Rando-mized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma", Journal of Clinical Oncology, 18, 773–779.
   Google Scholar
• Hochster, H.S., Oken, M.M., Winter, J.N., et al. (2000) "Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and long-term follow-up. A report from Eastern Cooperative Oncology Group", Journal of Clinical Oncology, 18, 987 —994.
   PubMed Web of Science ®Google Scholar
• Flinn, I.W., Byrd, J.C., Morrison, C., etal. (2000) "Fludarabine and cyclophosphamide with filgastrim support in patients with pre-viously untreated lymphoid malignancies", Blood, 96, 71–75.
   PubMed Web of Science ®Google Scholar
• Tsimberidou, A.M., McLaughlin, P., Younes, A., et al. (2002) "Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATI) regimen in patients with stage IV indolent lymphoma", Blood, 100, 4351 —4357.
   Google Scholar
• Harris, N.L., Jaffe, S.L., Diebold, J., et al. (1999) "World Health Organization classification of neoplastic diseases of the hemato-poietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting — Airlie House, Virginia, November 1977", Journal of Clinical Oncology, 12, 3835–3849.
   Google Scholar
• Kaplan, E.L. and Meier, P. (1958) "Non parametric estimation from incomplete observation", Journal of the American Statistical Association, 53, 457–481.
   Web of Science ®Google Scholar
• Cox, D.R. (1972) "Regression models and life tables", Journal of the Royal Statistical Society, 34, 187–220.
   Web of Science ®Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factors Project. (1993) "A predictive model for aggressive non-Hodgkin's lymphomas", The New England Journal of Medicine, 329, 987–994.
   PubMed Web of Science ®Google Scholar
• Gribben, J.G., Neuberg, D., Freedman, AS., et al. (1993) "Detection by polimerase chain reaction of residual cells with the bc1-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma", Blood, 81, 3449 — 3457.
   Google Scholar
• Freedman, AS., Gribben, J.G., Neuberg, D., et al. (1996) "High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission", Blood, 88, 2780— 2786.
   Google Scholar
• Czuczman, M.S., Grillo-Lopez, A.J., White, C.A., et al. (1999) "Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy", Journal of Clinical Oncology, 17, 268 — 276.
   Google Scholar
• Rambaldi, A., Manzoni, C., Baccarani, M., et al. (1999) "Rituximab sequentially administered to a first-line treatment with CHOP chemotherapy in follicular non-Hodgkin's lymphoma patients", Haematologica, 84\(suppl 10), 58 — 62.
   Google Scholar
• Rambaldi, A., Lazzari, M., Manzoni, C., et al. (2002) "Monitoring of residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma", Blood, 99, 856–862.
   Google Scholar
• Ladetto, M., Corradini, P., Vallet, S., et al. (2002) "High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)", Blood, 100, 1559 — 1665.
   Google Scholar